Scientific Advisory Board

Lung Cancer Foundation of America is proud to work with world renowned leaders in lung cancer research spanning a broad range of disciplines.

Members of the LCFA Scientific Advisory Board volunteer their time to

  • further LCFA’s mission through scientific and intellectual leadership
  • to consider and advise on proposals for new lung cancer research programs
  • to guide and advise on LCFA’s research investment
  • to provide grant review assessment
  • and to help determine research programs and ideas that will further the accomplishment of the LCFA Mission
  • Dr. Martin Edelman, MD

    Chair: Lung Cancer Foundation of America Scientific Advisory Board

    Fox Chase Cancer Center: Chair, Department of Hematology/Oncology

    Professor, Department of Hematology/Oncology Deputy Cancer Center Director for Clinical Research

  • Dr. Denise Aberle, MD

    Professor of Radiology in the School of Medicine and professor of Bioengineering in the Henry Samueli School of Engineering and Applied Sciences

  • Dr. Julie Brahmer, MD

    The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Director Thoracic Oncology Program Associate Professor of Oncology Interim

    Co-Director, Upper Aerodigestive (UAD) Program

    Interim Director, Johns Hopkins Kimmel Cancer Center at Bayview

  • Dr. David Carbone, MD, PhD

    Professor of Medicine in the Division of Medical Oncology, The Ohio State University – James Cancer Hospital and Solove Research Institute

  • Dr. Jessica Donington, MD

    Professor of Surgery Chief, Section of Thoracic Surgery, University of Chicago

  • Dr. Steven M. Dubinett, MD

    Professor of Medicine and Pathology, Director, UCLA Lung Cancer Research Program in the Jonsson Comprehensive Cancer Center. Chief, Division of Pulmonary and Critical Care Medicine, and Principal Investigator for the UCLA Lung Cancer SPORE

  • Dr. Bruce E. Johnson, MD

    Chief Clinical Research Officer Institute Physician, Lowe Center for Thoracic Oncology

    Professor of Medicine at Harvard Medical School

  • Dr. David H. Johnson, MD

    Emeritus

    Donald W. Seldin Distinguished Chair in Internal Medicine at UT Southwestern Medical Center in Dallas, Texas

    Chairman of the Department of Internal Medicine at UT Southwestern Medical Center in Dallas, Texas

  • Dr. Natasha B. Leighl, MD

    Lead Medical Oncologist, Princess Margaret Cancer Centre, Toronto, Canada

    Professor, Department of Medicine at the University of Toronto, Toronto, Canada

  • Dr. Raymond U. Osarogiagbon, MD

    Chief Scientist for Baptist Memorial Health Care, Director of Baptist Cancer Center’s Multidisciplinary Thoracic Oncology Program and Thoracic Oncology Research Group, and Principal Investigator of Baptist’s Mid-South Minority-Underserved Consortium initiative, NCORP, in Memphis, Tennessee

  • Dr. Michael Weitz, MD

    Associate Director Emergency Services, Saint Johns Health Center

    Assistant Clinical Professor of Medicine, Olive View UCLA Medical Center

    Lung Cancer Survivor